Entrada Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
TRDA chart
What traders are saying about $TRDA
Latest postsEntrada Therapeutics, Inc. news
- Entrada Therapeutics, Inc. Estimates – NASDAQ:TRDA
TradingView ·
- Entrada Therapeutics Appoints Linea Aspesi Chief People Officer to Support Pipeline Growth
citybiz ·
- Entrada Therapeutics, Inc. Announces Appointment of Linea Aspesi as Chief People Officer
www.marketscreener.com ·
- Entrada Therapeutics names Linea Aspesi as chief people officer
Investing.com ·
- Entrada Therapeutics names Linea Aspesi as chief people officer By Investing.com
Investing.com UK ·
- Entrada Therapeutics Appoints Linea Aspesi as Chief People Officer
Yahoo Finance ·
- Entrada Therapeutics names Linea Aspesi as Chie...
Pluang ·
- What's Going On With Entrada Therapeutics Stock Wednesday?
Yahoo Finance ·
- Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (DMD) in the Phase 1/2 ELEVATE-45-201 Study of ENTR-601-45
Yahoo Finance ·
- Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Top Dose of 18 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study
Yahoo Finance ·
- Entrada Therapeutics Announces Recipients of Fourth Annual DREAMS Grant Program
Yahoo Finance ·
- Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
Entrada Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $25.4M | $210.8M | $129.0M | – |
| Net income | -$143.8M | $65.6M | -$6.7M | -$94.6M |
| Diluted EPS | $-3.47 | $1.68 | $-0.20 | $-3.02 |
| Total assets (year end) | $377.4M | $526.3M | $469.2M | $252.1M |
| Cash and equivalents (year end) | $90.4M | $101.2M | $67.6M | $45.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Entrada Therapeutics, Inc.
- Ticker
- TRDA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1689375
- Former names
- CycloPorters, Inc.
Frequently asked questions
What exchange is Entrada Therapeutics, Inc. listed on?
Entrada Therapeutics, Inc. trades on the Nasdaq under the ticker symbol TRDA.
What industry is Entrada Therapeutics, Inc. in?
Entrada Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Entrada Therapeutics, Inc. headquartered?
Entrada Therapeutics, Inc.'s business address on file with the SEC is in Boston, MA.
When does Entrada Therapeutics, Inc.'s fiscal year end?
Entrada Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Entrada Therapeutics, Inc. report?
Entrada Therapeutics, Inc. reported $25.4M in revenue for calendar year 2025, according to its SEC filings.